We are live on ! Find out more
TNONW icon

Tenon Medical Inc Warrant

9 hedge funds and large institutions have $361K invested in Tenon Medical Inc Warrant in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

80% more funds holding

Funds holding: 59 (+4)

14% more capital invested

Capital invested by funds: $316K → $361K (+$44.4K)

6.62% more ownership

Funds ownership: 34.28%40.9% (+6.6%)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

TNONW Hedge Fund Activity: Q3 2023 in Review

9 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Tenon Medical Inc Warrant (TNONW) for Q3 2023, worth a combined $361K — up 14% from $316K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TNONW positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was TMD Wealth Management, opening a new position worth an estimated $377K. The largest seller was Armistice Capital, cutting an estimated $118K.

  • 9 institutional investors held Tenon Medical Inc Warrant (TNONW) as of Q3 2023, up from 5 in Q2 2023.
  • Funds reported $361K of Tenon Medical Inc Warrant stock for Q3 2023, up 14% quarter-over-quarter.
  • 4 funds opened new Tenon Medical Inc Warrant positions in Q3 2023 and 0 closed out, a net change of +4 holders.
  • The largest Tenon Medical Inc Warrant buyer in Q3 2023 was TMD Wealth Management, an estimated $377K added.
  • The largest Tenon Medical Inc Warrant seller in Q3 2023 was Armistice Capital, an estimated $118K sold.

Based on aggregated 13F filings for Q3 2023.